Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (639)
    • Blood Glucose Meters (3)
    • Complications (173)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (66)
    • Drug-Induced Hypo/Hyperglycemia (129)
    • Monitoring (117)
    • Natural Medicines/Supplements (11)
    • Prevention (56)
    • Treatment (316)
  • Endocrinology (11)
  • Hyperglycemia (26)
  • Hypoglycemia (27)
  • Other (26)
  • Prediabetes (5)
  • Resources (218)
  • Thyroid Disorders (48)
406 - 420 of 639 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Article: More diabetes patients will use insulin pumps December 2010
Article: Patients will be asking what to do now that rosiglitazone (Avandia, etc) use is being restricted December 2010
Other: Insulin Pump Therapy December 2010
Commentary: Restricted Use of Rosiglitazone Products (Avandia, Avandamet, and Avandaryl) December 2010
Article: possible link between Actos (pioglitazone) and bladder cancer October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Patient Education: Avandia and Risk of Heart Attack August 2010
Article: tighter control of blood glucose and lipids to slow the progression of diabetic retinopathy August 2010
Article: Many supplements are promoted for diabetes August 2010
Article: whether Avandia is riskier than Actos August 2010
Other: ACCORD Eye Study: Therapies to Slow Progression of Diabetic Retinopathy August 2010
Other: See new Health Canada information concerning the restricted use of Avandia August 2010
Commentary: Cardiovascular Safety of Rosiglitazone (Avandia) – 2010 Update August 2010
Article: Victoza (liraglutide) is the first NON-insulin injectable med for type 2 diabetes July 2010
  • « Prev
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved